Ignite Creation Date:
2024-05-05 @ 5:25 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00455208
Status:
UNKNOWN
Last Update Posted:
2009-02-19
First Post:
2007-03-30
Brief Title:
A Study Evaluating the Safety and Efficacy of Cura-100 in Subjects With Rheumatoid Arthritis and Osteoarthritis
Sponsor:
Cura Biotech LLC
Organization:
Cura Biotech LLC
Study Overview
Official Title:
Study Evaluating Cura-100 in Rheumatoid Arthritis and Osteoarthritis
Status:
UNKNOWN
Status Verified Date:
2007-03
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to evaluate the safety and efficacy of Cura-100 in treating rheumatoid arthritis and osteoarthritis
Detailed Description:
This is the Phase III trial which monitors both safety and efficacy of Cura-100 in subjects with rheumatoid arthritis and osteoarthritis at one clinical study center The open-label clinical study will be used in the study The study is expected to last for one and a half year after it has been officially started which include recruitment study treatment and follow-ups The healthy volunteers are also included to study the safety of the intervention
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None